Blueprint Medicines Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2021
Period Ending	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2017 - 2021
Operating Revenue	1.35	-	-	-	-	-	Upgrade
Other Revenue	-1.23	-	2.5	2.81	8.4	0.8	Upgrade
Revenue	0.12	-	2.5	2.81	8.4	0.8	Upgrade
Revenue Growth (YoY)	-97.54%	-	-11.13%	-66.51%	954.77%	-18.36%	Upgrade
Cost of Revenue	7.57	7.18	5.97	6.2	5.45	5.1	Upgrade
Gross Profit	-7.45	-7.18	-3.47	-3.39	2.95	-4.3	Upgrade
Selling, General & Admin	-	-	2.2	2.2	2.4	2.47	Upgrade
Other Operating Expenses	17.4	11.8	4.57	7.2	5.65	93.57	Upgrade
Operating Expenses	20.62	14.54	7.69	10.35	9.1	97.1	Upgrade
Operating Income	-28.07	-21.72	-11.16	-13.73	-6.15	-101.4	Upgrade
Interest Expense	-13.66	-19.82	-41.5	-41.5	-41.5	-41.5	Upgrade
Other Non Operating Income (Expenses)	4.51	4.51	-	-	-	-	Upgrade
EBT Excluding Unusual Items	-37.23	-37.04	-52.66	-55.23	-47.65	-142.9	Upgrade
Gain (Loss) on Sale of Assets	-	-	3.83	1.12	-	-	Upgrade
Other Unusual Items	845.36	845.36	-	-	-	-	Upgrade
Pretax Income	808.13	808.32	-48.83	-54.11	-47.65	-142.9	Upgrade
Income Tax Expense	8.36	8.36	24.36	17.34	-13.57	-	Upgrade
Net Income	799.77	799.96	-73.19	-71.45	-34.08	-142.9	Upgrade
Net Income to Common	799.77	799.96	-73.19	-71.45	-34.08	-142.9	Upgrade
Shares Outstanding (Basic)	13	13	13	13	13	13	Upgrade
Shares Outstanding (Diluted)	18	18	13	13	13	13	Upgrade
Shares Change (YoY)	31.82%	44.98%	-	-	-	-	Upgrade
EPS (Basic)	61.35	59.47	-5.74	-5.60	-2.67	-11.21	Upgrade
EPS (Diluted)	44.27	43.28	-5.74	-5.60	-2.67	-11.21	Upgrade
Free Cash Flow	-	-14.14	12.09	3.8	-2.01	9.41	Upgrade
Free Cash Flow Per Share	-	-0.77	0.95	0.30	-0.16	0.74	Upgrade
Gross Margin	-	-	-138.89%	-120.38%	35.14%	-	Upgrade
Operating Margin	-23589.92%	-	-446.70%	-488.41%	-73.28%	-12739.20%	Upgrade
Profit Margin	672075.63%	-	-2928.73%	-2540.93%	-405.92%	-17952.76%	Upgrade
Free Cash Flow Margin	-	-	483.83%	134.96%	-23.99%	1182.16%	Upgrade
EBITDA	-24.88	-18.98	-10.24	-12.79	-5.09	-100.34	Upgrade
EBITDA Margin	-	-	-	-	-60.65%	-	Upgrade
D&A For EBITDA	3.2	2.74	0.92	0.95	1.06	1.07	Upgrade
EBIT	-28.07	-21.72	-11.16	-13.73	-6.15	-101.4	Upgrade
EBIT Margin	-	-	-	-	-73.28%	-	Upgrade
Effective Tax Rate	1.03%	1.03%	-	-	-	-	Upgrade
Revenue as Reported	4.63	4.51	6.33	3.94	8.4	0.8	Upgrade

Updated Jan 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.